Improved liquid chromatography–tandem mass spectrometry method for the analysis of eptifibatide in human plasma-Reference-Cited by-同舟云学术

Improved liquid chromatography–tandem mass spectrometry method for the analysis of eptifibatide in human plasma

Published:2010-08 Issue:23 Volume:878 Page:2094-2100
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Zhou Zhi-Ling,Yu Xi-Yong,Yang Min,Mai Li-Ping,Lin Qiu-Xiong,Deng Chun-Yu,Shan Zhi-Xin,Kuang Su-Juan,Zhu Ping,Huang Xiao-Zhong,Li Xiao-Hong,Chen Tie-Feng,Lin Shu-Guang

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference6 articles.

1. Development of glycoprotein IIb–IIIa antagonists: translation of pharmacodynamic effects into clinical benefit

2. Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin

3. The role of eptifibatide in patients undergoing percutaneous coronary intervention

4. Determination of eptifibatide concentration in human plasma utilizing the liquid chromatography–tandem mass spectrometry method

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2019-06-13

2. Validated High Performance Liquid Chromatographic Method for Stability Study of Eptifibatide;Journal of Chromatographic Science;2019-04-20

3. Spectrofluorimetric determination of eptifibatide in human plasma and dosage form;Luminescence;2018-12-11

4. Differential mobility spectrometry followed by tandem mass spectrometry with multiple ion monitoring for bioanalysis of eptifibatide in rat plasma;Journal of Pharmaceutical and Biomedical Analysis;2018-03

5. Population pharmacokinetics and safety of eptifibatide in healthy Chinese volunteers and simulations on the dose regimens approved for a Western population;Int. Journal of Clinical Pharmacology and Therapeutics;2015-08-01